NanoViricides Inc. (NNVC)

[changes_iv]

If you find them funny, perhaps you should make the quotes your signature so that you can laugh every morning, if only for a while.

Here is what Dr. Eugene Seymour, CEO of NanoViricides Inc., said:

"by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials" ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.

On the CEO letter to shareholders (2014) he went to explain how would this be possible:

...The number of patients that need to be enrolled in a clinical trial depends upon how good the drug is. If the drug effect is very easily separated from the placebo, and more so, from the standard of care, then the trial would require fewer patients to reach the clinical end point of determining that the drug is indeed effective or superior, as the case may be. Therefore we believe, based on the very strong efficacy observed in our animal studies, that our influenza clinical trials will be short, and will be relatively inexpensive.